KOD Kodiak Sciences Inc

Price (delayed)

$31.52

Market cap

$1.98B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.19

Enterprise value

$2B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 3

Kodiak Sciences is a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics. We are focused on bringing new science to the design and manufacture of next-generation ...

Highlights
KOD's debt is down by 8% YoY and by 2.1% QoQ
The equity has declined by 45% since the previous quarter and by 13% year-on-year
Kodiak Sciences's quick ratio has decreased by 30% YoY and by 29% from the previous quarter

Key stats

What are the main financial stats of KOD

KOD stock price

How has the Kodiak Sciences stock price performed over time
Intraday
-6.75%
1 week
-3.81%
1 month
-17.77%
1 year
129.74%
YTD
12.73%
QTD
-19.1%

Financial performance

How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$246.42M
Net income
-$241.99M
Gross margin
N/A
Net margin
N/A
Kodiak Sciences's net income has decreased by 21% YoY and by 4.9% QoQ
The operating income has contracted by 19% YoY and by 4.8% from the previous quarter

Price vs fundamentals

How does KOD's price correlate with its fundamentals

Growth

What is Kodiak Sciences's growth rate over time

Valuation

What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
32.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 10% YoY
The equity has declined by 45% since the previous quarter and by 13% year-on-year
The stock's P/B is 30% above its last 4 quarters average of 26.7

Efficiency

How efficient is Kodiak Sciences business performance
KOD's return on equity has dropped by 76% year-on-year and by 8% since the previous quarter
KOD's ROIC is down by 49% year-on-year and by 11% since the previous quarter
The ROA has contracted by 35% YoY and by 4.9% from the previous quarter

Dividends

What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KOD.

Financial health

How did Kodiak Sciences financials performed over time
The total assets is 31% greater than the total liabilities
Kodiak Sciences's quick ratio has decreased by 30% YoY and by 29% from the previous quarter
KOD's current ratio is down by 30% since the previous quarter and by 28% year-on-year
KOD's debt is 150% higher than its equity
KOD's debt to equity has soared by 80% from the previous quarter and by 6% YoY
The equity has declined by 45% since the previous quarter and by 13% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.